Association of white matter hyperintensity measurements on brain mr imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors

American Journal of Neuroradiology

Volumn 30, Issue 10, 2009, Pages 1870-1876

  Appel, J ^a   Potter, E ^a   Bhatia, N ^a   Shen, Q ^a,b   Zhao, W ^b   Greig, M T ^a   Raj, A ^d,e   Barker, W W ^a   Potter, H ^d,e   Schofield, E ^d,f   Wu, Y ^d,f   Loewenstein, D A ^a,c,d   Duara, Ranjan ^a,c,d,e  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b University of Miami College of Engineering   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COGNITION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; RATING SCALE; RELIABILITY; RISK FACTOR; TEMPORAL LOBE; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CARDIOVASCULAR DISEASES; COGNITION; FEMALE; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; NERVE FIBERS, MYELINATED; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TEMPORAL LOBE;

EID: 71449122893     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1693     Document Type: Article

References (47)

1. Kapeller P, Barber R, Vermeulen RJ, et al. Visual rating of age-related white matter changes on magnetic resonance imaging. Stroke 2003;34:441-445
2. Fazekas F, Kapeller P, Schmidt R, et al. The relation of cerebral magnetic resonance signal hyperintensities to Alzheimer's disease. J Neurolog Sci 1996;142:121-125 (Pubitemid 26340420)
3. Wahlund LO, Barkhof F, Fazekas F, et al. A new scale for age-related white matter changes applicable to MRI and CT. Stroke 2001;32:1318-1322 (Pubitemid 32530416)
4. Flier WM, Barkhof F, Scheltens P. Shifting paradigms in dementia. Ann NY Acad Sci 2007;1097:215-224
5. Rosano C, Alzenstein H, Wu M, et al. Focal atrophy and cerebrovascular disease increase dementia risk among cognitively normal older adults. J Neuroimaging 2007;17:148-155 (Pubitemid 46624149)
6. Golomb, J, Kluger, A, Gionutsos, et al. Nonspecific leukoencephalopathy associated with aging. Neuroimaging Clin N Am 1995;5:33-44
7. Stolp H, Dziegielewska K. Role of developmental inflammation and bloodbrain barrier dysfunction in neurodevelopmental and neurodegenerative diseases. Neuropathol Appl Neurobiol 2009;35:132-146
8. Black S, Gao FQ, Bilbao J. Understanding white matter disease. Imaging-pathological correlations in vascular cognitive impairment. Stroke 2008;40:S48-52
9. Du AT, Schuff N, Chao LL, et al. White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy. Neurobiol Aging 2005;26:553-559 (Pubitemid 40093938)
10. Gouw A, Seewann H, Vrenken WM, et al. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain 2008;131:3286-3298
11. Englund E. Neuropathology of white matter changes in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 1998;9:6-12 (Pubitemid 28325636)
12. Young VG, Halliday GM, Kril JJ. Neuropathologic correlates of white matter hyperintensities. Neurology 2008;71:804-811
13. Bronge L, Bogdanovic N, Wahlund L-O. Postmortem MRI and histopathology of white matter changes in Alzheimer brains: a quantitative, comparative study. Dement Geriatr Cogn Disord 2002;13:205-212 (Pubitemid 34507605)
14. Jack CR, Dickson DW, Parisi JE, et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 2002;58:750-757
15. Bobinski M, de Leon MJ, Wegiel J, et al. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience 2000;95:721-725
16. Gosche KM, Mortimer JA, Smith CD, et al. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. Neurology 2002;58:1476-1482
17. Likeman M, Anderson VM, Stevens JM, et al. Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementias. Arch Neurol 2005;62:1410-1415 (Pubitemid 41352058)
18. Barkhof F, Polvikoski TM, van Straaten EC, et al. The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old. Neurology 2007;69:1521-1527 (Pubitemid 47537859)
19. Urs R, Potter E, Barker W, et al. Visual rating system for assessing magnetic resonance images: a tool in the diagnosis of mild cognitive impairment and Alzheimer Disease. J Comput Assist Tomogr 2009;33:73-78
20. Duara R, Loewenstein DA, Potter E, et al. Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer's disease. Neurology 2008;71:1986-1992
21. Roberts RO, Geda YE, Knopman DS, et al. Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol 2008;65:1066-1073
22. Roberts RO, Knopman DS, Geda YE, et al. Coronary heart disease is associated with non-amnestic mild cognitive impairment. Neurobiol Aging Dec 15. [Epub ahead of print]
23. Knopman DS, Roberts RO, Geda YE, et al. Association of prior stroke with cognitive function and cognitive impairment: a population-based study. Arch Neurol 2009;66:614-619
24. Petersen RD, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-1992 (Pubitemid 33143977)
25. Folstein M, Folstein S, McHugh P. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
26. Loewenstein DA, Barker WW, Harwood DG, et al. Utility of a modified Mini-Mental State Examination with extended delayed recall in screening for mild cognitive impairment and dementia among community dwelling elders. Int J Geriatr Psychiatry 2000;15:434-440
27. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414
28. Fuld PA. Fuld Object-Memory Evaluation. Wood Dale, Ill: Stoelting Co; 1981
29. Lacritz LH, Cullum CM, Weiner, M., et al. Comparison of the Hopkins Verbal Learning Test Revised to the California Verbal Learning Test in Alzheimer's Disease. Appl Neuropsychol 2001;8:180-184 (Pubitemid 32976971)
30. Golden, JC. Stroop Color and Word Test. Chicago: Stoelting Co; 1978
31. McKhann G, Drachman DA, Folstein MF, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944 (Pubitemid 14076461)
32. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308 (Pubitemid 29120227)
33. de Carli C, Murphy DG, Tranh M, et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 1995;45:2077-2084
34. Bombois S, Debette S, Delbeuck X, et al. Prevalence of subcortical vascular lesions and association with executive function in mild cognitive impairment subtypes. Stroke 2007;38:2595-2597 (Pubitemid 47329643)
35. Miller GA, Chapman JP. Misunderstanding analysis of covariance. J Abnorm Psychol 2001;110:40-48
36. de Leon MJ, Golomb J, George AE, et al. The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol 1993;14:897-906 (Pubitemid 23213382)
37. de Leon MJ, George AE, Golomb J, et al. Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging 1997;18:1-11 (Pubitemid 27062181)
38. Kantarci K, Jack CR, Xu YC, et al. Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. Radiology 2001;219:101-107 (Pubitemid 32234060)
39. van den Heuvel DM, ten Dam VH, de Craen AJ, et al. Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population. J Neurol Neurosurg Psychiatry 2006;77:149-153
40. Wright CB, Festa JR, Paik MC, et al. White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke 2008;39:800
41. Firbank MJ, Burton EJ, Barber R, et al. Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors. Neurobiol Aging 2007;11:1664-1669 (Pubitemid 47384946)
42. van de Pol LA, Korf ES, van der Flier WM, et al. Magnetic resonance imaging predictors of cognition in mild cognitive impairment. Arch Neurol 2007;64:1023-1028 (Pubitemid 47048004)
43. van Straaten EC, Harvey D, Scheltens P, et al. Alzheimer's Disease Cooperative Study Group: periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia. J Neurol 2008;255:1302-1308
44. Modrego PJ, Rios C, Pérez Trullen JM, et al. The cerebrovascular pathology in Alzheimer's disease and its influence on clinical variables. Am J Alzheimers Dis Other Demen 2008;23:91-96
45. Debette S, Bombois S, Bruandet A, et al. Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment. Stroke 2007;38:2924-2930 (Pubitemid 350041561)
46. Schneider JA, Arvanitakis Z, Bang W, et al. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007;69:2197-2204 (Pubitemid 350294674)
47. Reitz C, Tang MX, Manly J, et al. Hypertension and the risk of mild cognitive impairment. Arch Neurol 2007;67:1734-1740 (Pubitemid 350254935)